Colon Cancer Treatment - Exhibit makes colon test easy to digest - Tulsa World
Exhibit makes colon test easy to digest - Tulsa World
You might be afraid of getting a colonoscopy, but it is nothing compared to having cancer, said survivor Suzanne Bonner. “I’d like to tell people not to wait. Try to catch the cancer at stage one,” the 51-year-old Montana woman said. Bonner was
Avastin Setback For Roche - Forbes
Roche , the Swiss drugmaker that last February bought U.S. firm Genentech, saw its stock valuation being reduced on Wednesday after an early-stage colon cancer drug developed by its American partner missed a development milestone. Shares of Roche
Roche’s Avastin misses primary endpoint in late-stage study of colon - RTT News
(RTTNews) - Healthcare group Roche Holding AG (RHHBY.PK: News , RHHVF.PK), Wednesday, said that its first phase III trial on Avastin as an adjuvant therapy in colon cancer surgical patients did not meet the primary endpoint of disease-free survival
Pfizer And Bristol Beat Forecasts, But Sales Disappoint - Post Chronicle
Pfizer Inc and Bristol-Myers Squibb reported lower earnings that beat expectations on Tuesday, but the U.S. drugmakers relied on aggressive cost cuts to make up for disappointing sales. Pfizer cholesterol fighter Lipitor, the company’s biggest